Peer Review History
| Original SubmissionJune 19, 2020 |
|---|
|
PONE-D-20-18832 The effect of psychological distress on IVF outcomes: reality or speculations? PLOS ONE Dear Dr. Aimagambetova, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Both reviewers highlighted interesting points that need to be addresses by the Authors. In particular, points 1 and 3 raised by Reviewer 2 deserve great consideration. In addition, a sample size calculation is needed in order to verify whether the study has an appropriate power to support the conclusions. Please submit your revised manuscript by Oct 16 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Alessio Paffoni, PhD Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please amend your current ethics statement to address the following concerns: a) Did participants provide their written or verbal informed consent to participate in this study? b) If consent was verbal, please explain i) why written consent was not obtained, ii) how you documented participant consent, and iii) whether the ethics committees/IRB approved this consent procedure. 3. Thank you for stating the following in the Competing Interests section: "No authors have competing interest" We note that one or more of the authors are employed by a commercial company: IVF Clinic “Ecomed”. 3.1. Please provide an amended Funding Statement declaring this commercial affiliation, as well as a statement regarding the Role of Funders in your study. If the funding organization did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and/or research materials, please review your statements relating to the author contributions, and ensure you have specifically and accurately indicated the role(s) that these authors had in your study. You can update author roles in the Author Contributions section of the online submission form. Please also include the following statement within your amended Funding Statement. “The funder provided support in the form of salaries for authors [insert relevant initials], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ‘author contributions’ section.” If your commercial affiliation did play a role in your study, please state and explain this role within your updated Funding Statement. 3.2. Please also provide an updated Competing Interests Statement declaring this commercial affiliation along with any other relevant declarations relating to employment, consultancy, patents, products in development, or marketed products, etc. Within your Competing Interests Statement, please confirm that this commercial affiliation does not alter your adherence to all PLOS ONE policies on sharing data and materials by including the following statement: "This does not alter our adherence to PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests) . If this adherence statement is not accurate and there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared. Please include both an updated Funding Statement and Competing Interests Statement in your cover letter. We will change the online submission form on your behalf. Please know it is PLOS ONE policy for corresponding authors to declare, on behalf of all authors, all potential competing interests for the purposes of transparency. PLOS defines a competing interest as anything that interferes with, or could reasonably be perceived as interfering with, the full and objective presentation, peer review, editorial decision-making, or publication of research or non-research articles submitted to one of the journals. Competing interests can be financial or non-financial, professional, or personal. Competing interests can arise in relationship to an organization or another person. Please follow this link to our website for more details on competing interests: http://journals.plos.org/plosone/s/competing-interests 4. We note you have included a table to which you do not refer in the text of your manuscript. Please ensure that you refer to Table 5 and 6 in your text; if accepted, production will need this reference to link the reader to the Tables. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: I Don't Know Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: 1. Because patient distress can be highly correlated to their perception of their prognosis, the analysis should include a control for prognosis, such as AMH, AFC, FSH, etc 2. How many women were approached to get the total of 304? 3. I find the pregnancy rates to be exceptionally high. An average of 80% is extremely unusual. Is this the normal average pregnancy rate in the clinic? 4. please use a more updated reference for reference 29. Pasch et al have published more recent data in F&S The authors repeatedly state that stress, anxiety, and depression were correlated with pregnancy but depression was not. 5. The pregnancy rate of 08.1% in one of the subgroups feels unreal. Especially when an average of 2 embryos were transferred. Please reassess these results. 6. BMI should be controlled for in the analysis. Reviewer #2: Review comments Title: The effect of psychological distress on IVF outcomes: reality or speculations? This study investigates the rates of depression, anxiety and stress in women undergoing fertility treatement in Kazakhstan. Furthermore the present study explored if increased levels of depressive symptoms and anxiety influenced pregnancy outcome. Previously there haven't been exact numbers of how many women are burdened by the infertility or treatment nor if it has had any negative influence on pregnancy rates for women in the region of Kazakhstan, so it is very admirable that the authors seek to investigate. However there are some structural and language issues that need attention. General comments: There are places in the manuscript where the argumentation is very sparse. It would be better if you leave out some of the points and build the understanding for the points left rather than a lot of points with no reasoning. Then it becomes difficult to see the relevance of the point. It could be interesting if the authors disclosed a little more of the importance of why infertility might be so devastating for women in the region of central asia - some information is discussed in the end of the manuscript. I find this information very important and interesting. Also, discussing admissability to treatment. Introduction L. 72-74: It would be good if the authors explained from where they got these definitions of infertility, although they put in a reference, as there are differenct definitions according to country and region. L. 79-80: I would advise the authors to discuss the terms stress and distress, and when to use the nomination. It seems that due to sadness and dissapointment one would experience distress (emotional burden), whereas treatment in itself can be stressing and probably lead to distress. L. 81-84: The aregumenation is a little too superficial. I agree that stress and distress may influence autominic and endocrine responses, and this, is defintely very interesting. However, the argumentation lacks examples or referral to the specific studies - the 'how'. L. 85-88: This is true - but this paragraph seem to be associated with former paragraphs explaining that couples are distressed or that infertility and fertility treatment might be stressing. Be aware that you don't jump around with different themes. L.103: What does REI stand for? Methods L- 112: How many patients were approached? Did the women themselves decide if they wanted to take part in teh study? L. 118: You might want to specify that two clinics were in the same city??? 3 clinics - two cities. L. 125: When did they fill-out the baseine questionnaire? L. 129: What kind of medical history information was gathered? Previous depressions, anxiety - treatments? Prescribed medication? L.140-146: Why did you choose CES-D? And what is the average score of the Kazakhstan population? or regional data? L.187: I believe that The Results section should be a header in itself and not presented under 'methods'. Results L. 189: How many did you approach - how many declined to particioate? Do you know why? A flowchart will give us a nice overview. L. 190: definition of normal BMI (also in a cultural perspective). Also it is unclear, if women who conceived were in first, second or more cycles. It would be beneficial to add this information to your table (the frequency of pregnacy rate for each cycle). L. 220-222: from what perspective? Do you have any regional data to compare with? Again a table with an overview of the descriptive reginal data would make it much easier to understand the differences. L.230-233: I am a little usure that I understand this paragraph correctly. If you controlled for the variables mentionned then the association between FPI global stress was still significant or not significant for pregnancy outcome? You may want to consider 'main' analyses and then explorative analyses e.g. looking into specific domains association with pregnancy. It is a little muddled. Discussion Overall, the discussion is long. You may want to shorten it a bit. L.251-261: This is a very interesting discussion point indeed, however as you don't yourselves present any biological/physiological data it seems a little odd to present it here. You are speculating whether this might be an explanation for your findings. L.272-281: What is the main reason for this paragraph? You might want to leave it out. As it doesn't add to your main objective. L. 301: If you did power calculations accordingly to the number of participants you needed, it would be a good idea to present this information in the Methods section, as this is defintely a strength. L. 313-315: This is an interesting result, wy isn't this dicussed further? ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
The effect of psychological distress on IVF outcomes: reality or speculations? PONE-D-20-18832R1 Dear Dr. Aimagambetova, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Alessio Paffoni, PhD Academic Editor PLOS ONE Additional Editor Comments (optional): The manuscript met the reviewers' recommendations positively. The limitations which still exist have been sufficiently discussed. I believe the manuscript meets the requirements for publication at this point. Reviewers' comments: |
| Formally Accepted |
|
PONE-D-20-18832R1 The effect of psychological distress on IVF outcomes: reality or speculations? Dear Dr. Aimagambetova: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Alessio Paffoni Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .